Clinical Outcomes of Patients with MGUS and Diabetes/Obesity on GLP-1 Receptor Agonists: A Real-World, Propensity-Matched Study

Ioannis Ntanasis‐Stathopoulos; Anastasios Tentolouris; Charalampos Filippatos; Αlexandros Briasoulis; Meletios A Dimopoulos; Maria Gavriatopoulou

doi:10.1016/s2152-2650(25)03827-3

Back

Clinical Outcomes of Patients with MGUS and Diabetes/Obesity on GLP-1 Receptor Agonists: A Real-World, Propensity-Matched Study

Article 2025 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2025

GLP‐1 receptor agonists in patients with MGUS: A real‐world propensity‐matched study

Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Evangelos Terpos, Efstathios Kastritis, Ernesto Ruiz Duque, Meletios A Dimopoulos, Maria Gavriatopoulou, Αlexandros Briasoulis

Article2024

SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation

Yi‐Hsin Chan, Tze‐Fan Chao, Shao-Wei Chen, Hsin‐Fu Lee, Pei‐Ru Li, Yung‐Hsin Yeh, Chi‐Tai Kuo, Lai‐Chu See, Professor Gregory Lip

Letter2025

GLP-1 receptor agonists: even for kidney transplant recipients with pre-existing diabetes?

Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi

Article2018

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

José Miguel Rivera‐Caravaca, María Asunción Esteve‐Pastor, Francisco Marı́n, Mariano Valdés, Vicente Vicente, Vanessa Roldán, Professor Gregory Lip

Article2025

<scp>GLP</scp> ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity

Tommaso Bucci, Uazman Alam, Grégoire Fauchier, Lisa Lochon, Arnaud Bisson, Pierre Henri Ducluzeau, Professor Gregory Lip, Laurent Fauchier